Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group (Q77292359)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 1998

Language	Label	Description	Also known as
English	Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group	scientific article published on 01 March 1998

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

monoclonal antibody

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Richard G. Wunderink

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

E Abraham

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Anzueto

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G Gutierrez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Tessler

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G San Pedro

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Dal Nogare

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Nasraway

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Berman

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Cooney

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

H Levy

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Baughman

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Rumbak

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R B Light

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

L Poole

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Allred

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Constant

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Pennington

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Porter

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

351

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

9107

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

929-933

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Anti-endotoxin monoclonal antibodies--a second look

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of septic shock: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of sepsis syndrome in 8 academic medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of coagulation after administration of tumor necrosis factor to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal anti-tumor necrosis factor (TNF) antibodies protect mouse and human cells from TNF cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A bioassay for the detection of tumor necrosis factor from eight different species: evaluation of neutralization rates of a monoclonal antibody against human TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2960602-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)60602-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734938%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77292359&oldid=1722267856"